Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for Barrett's esophagus.

Stuart Jon Spechler1

  • 1Dallas Department of Veterans Affairs Medical Center and The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.

Reviews in Gastroenterological Disorders
|December 13, 2002
PubMed
Summary

Screening for Barrett's esophagus may help prevent esophageal cancer deaths. However, the cost-effectiveness of screening and surveillance remains debated, with computer models offering varied insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD.

American journal of physiology. Gastrointestinal and liver physiology·2026
Same author

In Obesity, Esophagogastric Junction Fat Impairs Esophageal Barrier Function and Dilates Intercellular Spaces via Hypoxia-Inducible Factor 2α.

Gastroenterology·2024
Same author

Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.

Gut·2024
Same author

Th2 cytokine signaling through IL-4Rα increases eotaxin-3 secretion and tension in human esophageal smooth muscle.

American journal of physiology. Gastrointestinal and liver physiology·2023
Same author

Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma?

The American journal of gastroenterology·2023
Same author

Response to Haseeb et al.

The American journal of gastroenterology·2022

Area of Science:

  • Gastroenterology
  • Oncology
  • Health Economics

Background:

  • Barrett's esophagus is a precursor to esophageal adenocarcinoma.
  • Screening and surveillance aim to prevent deaths from this cancer.
  • The cost-effectiveness of these strategies is debated due to uncertain cancer risk data.

Purpose of the Study:

  • To discuss the cost-effectiveness of screening and surveillance for Barrett's esophagus.
  • To highlight the need for accurate risk estimates in this condition.
  • To evaluate the role of endoscopic screening in identifying high-risk patients.

Main Methods:

  • Review of existing evidence on screening and surveillance efficacy.
  • Analysis of computer models simulating cost-effectiveness.
  • Discussion of the limitations of current data and modeling approaches.

Main Results:

  • Computer models are used to estimate cost-effectiveness in the absence of definitive clinical data.
  • Indirect evidence suggests potential benefits of surveillance.
  • There is significant debate regarding the efficacy of these diagnostic procedures.

Conclusions:

  • Accurate risk assessment is crucial for discussing cost-effectiveness.
  • Computer models provide insights but not definitive answers on screening and surveillance.
  • Further research is needed to clarify the benefits and costs of Barrett's esophagus management.

Related Experiment Videos